Stock FENNEC PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Fennec Pharmaceuticals Inc. Nasdaq

Equities

CA31447P1009

Real-time Estimate Cboe BZX
Other stock markets
 17:09:07 30/05/2024 BST 		5-day change 1st Jan Change
7.2 USD 0.00% Intraday chart for Fennec Pharmaceuticals Inc. 0.00% 0.00%
05-15 HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating MT
05-14 Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Fennec Pharmaceuticals : Corporate Presentation May 2024
PU
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GL
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
GL
Fennec Pharmaceuticals : Corporate Presentation March 2024
PU
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
GL
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
GL
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
AQ
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
GL
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
GL
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
AQ
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
GL
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
AQ
Fennec Announces Incremental $5 Million Investment from Petrichor
GL
Fennec Announces Incremental $5 Million Investment from Petrichor
AQ
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
GL
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
AQ
Fennec Pharmaceuticals : Corporate Presentation November 2023
PU
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update
GL
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update
AQ
Substitute Claims Upheld As Prior Art Is Inapplicable To Pharmaceutical Compositions
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FENC Stock
  4. Stock
  5. News Fennec Pharmaceuticals Inc.
  6. Press Releases